Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
Simple search

Simple search

*
(*) mandatory field




 

Other search option(s)

91 matching term(s)

Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-OUEN-L'AUMÔNE
    • Accreditation
    • Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
    • Laboratoire Cerba
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Accreditation
    • Diagnosis of essential thrombocythemia
    • CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular cytogenetic diagnosis of chronic myeloproliferative disease
    • Charité - Universitätsmedizin Berlin (CVK)
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of myeloproliferative disorders (JAK2(V617F), MPL, TET2 genes)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of chromosomal aberrations in AML, ALL, CML, AUL, CMML, MPN
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
    • Labor Lademannbogen
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular cytogenetic diagnosis of essential thrombocythemia (CEP8 (8p11.1-q11.1), Chr.9: abl (9q34), Chr. 13: D13S319 (13q14.3)/ 13q34, TP53 (17p13.1), D20S108 (20q12))
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • SWITZERLAND
    • Suisse Romande
    • SION
    • Accreditation
    • Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
    • Institut Central des Hôpitaux Valaisans (ICHV)
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative diseases (JAK2: by mutation analysis for V617F)
    • Sheffield Children's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Molecular monitoring of donor chimerism post stem cell transplantation
    • Sheffield Children's NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • Accreditation
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene: V617 mutation)
    • Birmingham Women's NHS Foundation Trust
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
    • Gemeinschaftspraxis Dr. Prager / Dr. Junge / Dr. Hennig / Dr. Linné
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Accreditation
    • Molecular diagnosis of essential thrombocythemia (V617F mutation of the JAK2 gene)
    • Allgemeines Krankenhaus der Stadt Wien
    • More information
    • UNITED KINGDOM
    • Devon
    • EXETER
    • Accreditation
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
    • Royal Devon and Exeter Hospital - Wonford site
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
    • Medizinische Hochschule Hannover
    • More information
    • UNITED KINGDOM
    • Avon
    • BRISTOL
    • Accreditation
    • Molecular haemato-oncology diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation and exon 12 analysis)
    • Southmead Hospital
    • More information
    • UNITED KINGDOM
    • Avon
    • BRISTOL
    • Accreditation
    • Molecular diagnosis of Chronic myeloproliferative disease (MPL gene)
    • Southmead Hospital
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Accreditation
    • Molecular diagnosis of myeloproliferative diseases : search for V617F mutation in JAK2 gene by ARMS-PCR
    • BioAnalytica-GenoType SA
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of myeloproliferative disorders (JAK2 (exon 12, exon 14 (V617F)), MPL (exon 10), TET2 (exon 3-11) and PRV1 genes)
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular cytogenetic and cytogenetic diagnosis of chronic myeloproliferative disorders (translocations: t(3q26) [EVI1] deletions: 4q24 [TET2], 5q31 [EGR1] / 5q33-q34 [CSF1R], 7q22.1/7q31 [RELN/TES], 17p13 [TP53], 20q12 [MYBL2] numeric: -7 [RELN/TES], +8 [cen8], -Y [cen Y])
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular cytogenetic and cytogenetic diagnosis of myeloproliferative disorders (translocations: t(9;22) [BCR/ABL1], t(5q31-q33) [PDGFRB], deletions: 4q24 [TET2], 20q12 [MYBL2] numeric: +8 [cen8]
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (TET2 gene (exon 3-11), JAK2 gene (V617F), TP53 (exon 4-9))
    • Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: sequencing / MLPA)
    • Centogene AG
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • VALENCIENNES
    • Accreditation
    • Molecular diagnosis of malignant haemopathies
    • Centre Hospitalier de Valenciennes
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • VALENCIENNES
    • Accreditation
    • Cytogenetic diagnosis of malignant haemopathies
    • Centre Hospitalier de Valenciennes
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular diagnosis of Myeloproliferative disorders (JAK2 gene:mutation V617F: ARMSPCR and pyrosequencing, 9q24)
    • Salisbury District Hospital
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
    • MVZ Fenner & Krasemann
    • More information
    • SWEDEN
    • Landstinget i Östergötland
    • LINKÖPING
    • Accreditation
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
    • Linköping University Hospital
    • More information
    • ITALY
    • VENETO
    • PADOVA
    • Accreditation
    • Molecular diagnosis of myeloproliferative diseases (JAK2 gene)
    • Azienda Ospedaliera di Padova
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
    • DRK Baden-Württemberg/ Hessen
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Accreditation
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
    • CeGaT GmbH
    • More information
    • BELGIUM
    • LIEGE
    • LIEGE
    • Accreditation
    • Molecular diagnosis of essential thrombocythemia and primary myelofibrosis (CALR gene)
    • CHU de LIEGE - UniLab Lg
    • More information
    • FRANCE
    • FRANCHE-COMTE
    • BESANÇON
    • Molecular cytogenetic diagnosis of malignant hemopathies
    • CHRU de Besançon - Hôpital Saint-Jacques
    • More information
    • FRANCE
    • BRETAGNE
    • BREST
    • Molecular diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation and exon 12 analysis)
    • CHRU de Brest - Hôpital Morvan
    • More information
    • FRANCE
    • MIDI-PYRENEES
    • TOULOUSE
    • Cytogenetic diagnosis of myeloid hemopathies
    • CHU de Toulouse - Hôpital Purpan
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Cytogenetic diagnosis of malignant hemopathies
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • More information
    • FRANCE
    • PICARDIE
    • AMIENS
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
    • CHU d'Amiens - Hôpital Sud
    • More information
    • ITALY
    • FRIULI VENEZIA GIULIA
    • UDINE
    • Molecular diagnosis of thrombocythemia (JAK2, MPL genes)
    • Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
    • More information
    • GERMANY
    • Schleswig-Holstein
    • KIEL
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
    • Universitätsklinikum Schleswig-Holstein - Campus Kiel
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular cytogenetic and cytogenetic diagnosis of myeloproliferative neoplasias
    • Azienda Ospedaliera "San Paolo" - Universitŕ degli Studi di Milano
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene / mutation V617F/G1849T)
    • Hospital Universitario Donostia
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
    • Klinikum Stuttgart - Standort Olgahospital
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular cytogenetic diagnosis of malignant haemopathies
    • Instituto Portuguęs de Oncologia do Porto, EPE / IPOFG - CRO Porto
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of chronic myeloproliferative diseases (JAK2 gene / PCR)
    • Hospital Universitario La Fe - Campanar
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of myelodysplastic syndromes and myeloid hemopathy (TET2 gene / PCR)
    • Hospital Universitario La Fe - Campanar
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular cytogenetics diagnosis of essential thrombocythemia (FISH t(9;22), JAK2 gene: mut. V617F, exon 12; MPL gene: codon 505, 515)
    • Centro Inmunológico de Alicante (CIALAB)
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of myeloproliferative disorder with oesinophilia (PDGFRB gene)
    • Genetiks - Genetic diagnosis and research center
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of chronic myeloproliferative syndromes (JAK2 gene)
    • Genetiks - Genetic diagnosis and research center
    • More information
    • SLOVENIA
    • SLOVENIA
    • LJUBLJANA
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F mutation)
    • University Medical Center Ljubljana
    • More information
    • FRANCE
    • AQUITAINE
    • PESSAC
    • Molecular and cytogenetic diagnosis of chronic myeloproliferative disorders (V617F detection and exon 12 sequencing of JAK2 gene)
    • CHU de Bordeaux-GH Sud - Hôpital Haut-Lévęque
    • More information
    • LITHUANIA
    • DZUKIJA
    • VILNIUS
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene:mutation V617F)
    • Vilnius University Hospital Santariskiu Klinikos
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
    • Diagenom GmbH
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Cytogenetic/ molecular cytogenetic diagnosis of chronic myeloproliferative disorders
    • Diagenom GmbH
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of myeloproliferative disorders (MPL gene)
    • Genetaq
    • More information
    • FRANCE
    • ALSACE
    • COLMAR
    • Molecular diagnosis of myeloproliferative syndromes (JAK2 gene : V617F mutation)
    • Hôpital Pasteur - Hôpitaux civils de Colmar
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • NÎMES
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
    • CHU de Nîmes - Hôpital Caremeau
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • TROYES
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 and MPL genes)
    • CHG Les Hauts Clos
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • SAINT-MANDÉ
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
    • Hôpital d'Instruction des Armées Bégin
    • More information
    • ITALY
    • LOMBARDIA
    • BRESCIA
    • Molecular diagnosis of myeloproliferative diseases (JAK2 gene)
    • Biodiversity
    • More information
    • FRANCE
    • LORRAINE
    • METZ
    • Molecular diagnosis of myeloproliferative diseases (JAK gene: V617F mutation)
    • CHR de Metz-Thionville
    • More information
    • FRANCE
    • LORRAINE
    • METZ
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular cytogenetic diagnosis of myeloproliferative neoplasm (FISH)
    • Hospital Universitario Central de Asturias
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Cytogenetic diagnosis of myeloid hemopathies (classical caryotype and FISH)
    • CHU de Strasbourg - Hôpital de Hautepierre
    • More information
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Molecular and molecular cytogenetic diagnosis of Myeloproliferative neoplasm (BCR/ABL1, JAK2 (V617F and exon 12 mut), MPL (S505 and W515 mut), FIP1L1/PDGFRA
    • Cambridge University Hospitals NHS Foundation Trust
    • More information
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • KIT (D816V): Molecular diagnosis of Chronic Myeloid Leukaemia (BCR/ABL1: by PCR, RT-PCR and FISH)
    • Cambridge University Hospitals NHS Foundation Trust
    • More information
    • SPAIN
    • Cataluńa
    • TARRAGONA
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene / mutation V617F; CALR gene / mutations in exon 9)
    • Hospital Universitari de Tarragona Joan XXIII
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • CRÉTEIL
    • Molecular diagnosis of myeloproliferative syndromes (JAK2 gene : V617F mutation ; TET2)
    • GH Henri Mondor
    • More information
    • FRANCE
    • BRETAGNE
    • RENNES
    • Molecular diagnosis of myeloproliferative neoplasm (JAK2 gene by PCR, QPCR)
    • CHU de Rennes - Hôpital Pontchaillou
    • More information
    • ITALY
    • CALABRIA
    • REGGIO CALABRIA
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene)
    • Azienda Ospedaliera BMM
    • More information
    • ITALY
    • LOMBARDIA
    • PAVIA
    • Cytogenetic, molecular and molecular cytogenetic diagnosis of essential thrombocythemia
    • Fondazione IRCCS Policlinico San Matteo
    • More information
    • SPAIN
    • Galicia
    • A CORUŃA
    • Molecular cytogenetics and molecular diagnosis of chronic myeloproliferative disorders (t(9;22) [BCR/ABL] - FISH/PCR/QPCR, JAK2 gene - V617F mutation, exon12 (PCR))
    • Complejo Hospitalario Universitario A Coruńa
    • More information
    • PORTUGAL
    • CENTRO
    • COIMBRA
    • Molecular diagnosis of Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis (JAK2 gene): V617F mutation and exon 14 quantification (RT-PCR).
    • Hosp. Pediátrico e Hosp. Covőes - Centro Hospitalar e Universitário de Coimbra
    • More information
    • ITALY
    • PUGLIA
    • SAN GIOVANNI ROTONDO
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene)
    • IRCCS Ospedale Casa Sollievo della Sofferenza - Polamb. Giovanni Paolo II
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Molecular diagnosis of Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis by JAK2 analysis
    • Central Manchester University Hospitals - Manchester Royal Infirmary
    • More information
    • SPAIN
    • La Rioja
    • LOGROŃO
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene)
    • Hospital San Pedro
    • More information
    • GREECE
    • THESSALONIKI
    • THESSALONIKI
    • Molecular cytogenetics diagnosis of myeloproliferative diseases
    • Theagenion Cancer Centre of Thessaloniki
    • More information
    • LEBANON
    • Beyrouth
    • BEIRUT
    • Molecular diagnosis of myeloproliferative syndromes (V617F mutation of JAK2 gene)
    • Université Saint-Joseph
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene / mutation V617F)
    • DNA Data
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • BRNO
    • Molecular diagnosis of myeloproliferative neoplasms (JAK2 gene)
    • University hospital Brno
    • More information
    • MOROCCO
    • Rabat
    • RABAT
    • Molecular cytogenetics diagnosis of acute lymphoblatic and myeloblastic leukaemia, myeloproliferative and myelodysplastic syndromes
    • Institut National d'Hygične
    • More information
    • ROMANIA
    • CLUJ
    • CLUJ-NAPOCA
    • Molecular diagnosis of chronic myeloproliferative diseases (V617F mutation of JAK2 gene)
    • Spitalul Judetean Clinc de Urgenta Cluj
    • More information
    • SERBIA
    • Serbia
    • BELGRADE
    • Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
    • Institute of Molecular Genetics and Genetic Engineering
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • NICE
    • Molecular diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation)
    • CHU de Nice - Hôpital Pasteur
    • More information
    • CZECH REPUBLIC
    • Olomouc
    • OLOMOUC
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
    • University hospital Olomouc
    • More information
    • CZECH REPUBLIC
    • South Bohemia
    • CESKE BUDEJOVICE
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
    • Hospital Ceské Budejovice
    • More information
    • SPAIN
    • Madrid
    • SAN SEBASTIÁN DE LOS REYES
    • Molecular diagnosis of essential thrombocythemia (JAK2 gene/V617F, K539L and V607N mutations)
    • Laboratorio de Genética Clínica, S.L.
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
    • IHIT Instytut Hematologii I Transfuzjologii
    • More information
    • POLAND
    • Bydgoszcz
    • BYDGOSZCZ
    • Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
    • More information
    • SPAIN
    • Madrid
    • MAJADAHONDA
    • Molecular diagnosis of myeloproliferative disorders related to JAK2
    • Genyca Innova
    • More information
    • FRANCE
    • CENTRE
    • CHAMBRAY-LES-TOURS
    • Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
    • SELAS Arnaud-Biolys-Origet
    • More information